You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 2, 2026

Profile for Chile Patent: 2020002637


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Chile Patent: 2020002637

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Sep 18, 2041 Novartis PLUVICTO lutetium lu-177 vipivotide tetraxetan
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of Chile Patent CL2020002637: Scope, Claims, and Patent Landscape

Last updated: August 9, 2025

Introduction

Patent CL2020002637, filed and granted in Chile, pertains to a pharmaceutical invention, reflecting the country's evolving drug patent landscape. This analysis examines the scope and claims of the patent, contextualizes its patent landscape within Chile's intellectual property (IP) framework, and provides insights relevant to industry stakeholders, legal practitioners, and R&D firms.

Overview of Patent CL2020002637

Patent CL2020002637 is associated with a specific pharmaceutical formulation or compound, granted in 2020, as part of Chile’s commitments under the Patent Cooperation Treaty (PCT) and the territorial IP laws. Although detailed technical disclosures are proprietary, publicly available patent documents detail the core inventive features and legal scope.

Scope of the Patent

Legal Boundaries and Territorial Extent

Chile’s patent law assigns a twenty-year enforceable duration from the filing date, with the scope limited geographically to Chile’s jurisdiction. The scope encompasses the protection conferred by the claims, which define the precise technical elements the patent owner seeks to enforce.

Technical Scope

The patent ostensibly protects a pharmaceutical compound or formulation, potentially with specific uses, manufacturing processes, or delivery mechanisms. Given typical pharmaceutical patent strategies, the scope likely concentrates on:

  • The novel molecular structure or pharmaceutical composition.
  • A specific use or therapeutic indication.
  • A unique process for synthesis or formulation.

The scope's breadth varies depending on claim language: broad claims may cover entire classes of compounds or methods, whereas narrow claims focus on particular molecules or formulations.

Claim Analysis

Patent claims form the core legal measure of the patent's scope. A typical pharmaceutical patent includes:

  • Independent Claims: Define the essential features of the invention, often including the chemical structure, formulation, or method.

  • Dependent Claims: Narrower, building upon independent claims, adding specific features or embodiments.

Example Hypothetical Claims (based on standard pharmaceutical patents):

  • Claim 1: A pharmaceutical composition comprising a compound of formula [structure], wherein said compound exhibits activity against [target disease].

  • Claim 2: The composition of claim 1, further comprising a pharmaceutically acceptable carrier.

  • Claim 3: A method for treating [disease] comprising administering an effective amount of the compound of claim 1.

The enforceability of these claims hinges on their specificity and novelty. Broad claims might be vulnerable to challenges for lack of inventive step or novelty, whereas narrow claims might be easier to invalidate or design-around.

Claim Strategy and Protectable Scope

The patent’s enforceability and commercial value depend on:

  • The novelty and inventive step against prior art.
  • The non-obviousness of claiming specific chemical structures or formulations.
  • The inclusion of use claims, which extend protection to therapeutic applications.

It’s vital to evaluate whether the claims encompass the actual innovation or are merely minor modifications of known compounds or methods.

Patent Landscape in Chile: Pharmaceutical Patent Dynamics

Legal Framework & Patentability Criteria

Chile's IP law (Law No. 19.039, amended by Law No. 20.469 and subsequent reforms) harmonizes with international standards, requiring that:

  • Patents are granted for inventions capable of industrial application.
  • The invention is new, involves an inventive step, and is susceptible to industrial application.
  • Methods of medical treatment are generally patentable as chemical inventions but not as procedures for surgical or therapy purposes under strict interpretations.

Recent Trends and Considerations

  • Chile’s patent office (INAPI) aligns with international best practices, reviewing pharmaceutical patents rigorously for novelty and inventive step.
  • The scope of patent claims for pharmacological inventions often faces scrutiny owing to the World Trade Organization’s (WTO) provisions balancing patent rights and public health.
  • Chile continues to implement patent examination procedures that assess prior art comprehensively, impacting the scope of granted patents.

Patent Filing and Portfolio Strategy

Pharmaceutical firms routinely file multiple patents within Chile to secure market exclusivity for different aspects:

  • Compound-specific patents.
  • Formulation patents.
  • Method-of-use patents.

In the context of CL2020002637, strategic considerations include how broad or narrow claims are, and whether supplemental IP rights, such as data or regulatory exclusivities, complement patent protection.

Litigation and Patent Challenges

Patent validity in Chile is often challenged through nullity actions (annulment proceedings), emphasizing the importance of robust claim construction and patent prosecution history. Maintaining patent strength involves strategic claim drafting and continuous monitoring of prior art.

Competitive Landscape

Chile's pharmaceutical patent environment is characterized by:

  • A moderate pipeline of patent filings, often driven by local innovators and multinationals seeking regional protection.
  • Increasing patent applications for biologics and specialty drugs, reflecting global industry trends.
  • Competition from generic manufacturers post-expiry, emphasizing the importance of broad, enforceable patents.

Patent CL2020002637 appears to serve as a key component in the patent portfolio of its owner, potentially blocking competitors from producing similar formulations or uses.

Implications for Industry Stakeholders

  • Innovators: Need to ensure patent claims are comprehensive yet defensible to maximize exclusivity.
  • Generic Manufacturers: Must assess claim scope and validity for potential challenges or design-around strategies.
  • Legal Practitioners: Should focus on patent prosecution strategies that anticipate PTO scrutiny, especially with narrow claims.
  • Regulatory Agencies: Consider the interplay between patent rights and access to medicines, balancing innovation incentives with public health.

Key Takeaways

  • Scope and Claims: The patent likely covers specific chemical entities, formulations, or methods associated with a particular pharmaceutical compound, with scope contingent on claim language’s breadth and specificity.
  • Patent Landscape: Chile's pharmaceutical IP environment adheres to international standards, with an increasing focus on patent quality, particularly regarding patents for drugs with complex formulations or methods.
  • Strategic Considerations: Crafting well-drafted claims that delineate the invention’s novelty, while avoiding overlap with prior art, is vital for maintaining enforceability.
  • Enforcement and Challenges: Patent validity can be contested; therefore, a thorough examination of prior art and clear claim delineation are essential.
  • Market Dynamics: Patents like CL2020002637 enable exclusivity, fostering R&D investment, but also require vigilant monitoring of patent landscapes and potential infringing activities.

FAQs

1. What is the typical scope of pharmaceutical patents like CL2020002637 in Chile?
They generally cover specific chemical compounds, formulations, or methods of use, with scope defined by the language of the claims. Broader claims offer wider protection but may face higher patentability hurdles.

2. How does Chile’s patent law influence the patentability of drug inventions?
Chile requires novelty, inventive step, and industrial applicability. It also permits patenting chemical inventions and certain methods, aligning with international standards, but excludes patents for surgical or purely medical treatment methods.

3. Can a competitor bypass a patent like CL2020002637?
Yes, through design-around strategies that avoid infringing the specific claims or by challenging the patent’s validity based on prior art or lack of inventive step.

4. How does the patent landscape in Chile affect drug developers?
It encourages innovation while enforcing strict patentability standards, emphasizing comprehensive patent prosecution and strategic claim drafting to secure market exclusivity.

5. What role do patent challenges play in the pharmaceutical landscape?
Challenging patents through nullity actions helps ensure that only innovative, non-obvious inventions receive protection, balancing patent rights with public health and market competition.


Sources
[1] Chilean Patent Law No. 19.039, as amended.
[2] INAPI Official Patent Database.
[3] WIPO, Patent Database.
[4] World Trade Organization, TRIPS Agreement.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.